Literature DB >> 11015692

Effect of zinc binding and precipitation on structures of recombinant human growth hormone and nerve growth factor.

T H Yang1, J L Cleland, X Lam, J D Meyer, L S Jones, T W Randolph, M C Manning, J F Carpenter.   

Abstract

Metal-induced precipitation of protein therapeutics is being used and further developed as a processing step in protein formulation and may have utility in protein purification and bulk storage. In such processes, it is imperative that native protein structure is maintained and the metal complexation is reversible. In the current study, we investigated the effects of zinc-induced precipitation on recombinant human growth hormone (rhGH) and recombinant human nerve growth factor (rhNGF). On the addition of ethylenediaminetetraacetic acid (EDTA), the precipitates were dissolved, yielding complete recovery of native protein in both cases. Both proteins have specific metal binding sites and require specific molar ratios of zinc to protein to initiate precipitation (zinc:rhGH > 2:1; zinc:rhNGF > 18:1). Furthermore, the secondary structures of both proteins were unperturbed in soluble zinc complexes and zinc-induced precipitates, as measured by infrared and circular dichroism spectroscopies. The soluble zinc complex of rhGH had minor tertiary structural alterations, whereas zinc binding did not alter the tertiary structure of rhNGF. These studies indicated that metal-induced precipitation provides a method to maintain proteins in their native state in precipitates, which may be useful for purification, storage, and formulation. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015692     DOI: 10.1002/1520-6017(200011)89:11<1480::aid-jps10>3.0.co;2-m

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  A quantitative model of thermal stabilization and destabilization of proteins by ligands.

Authors:  Piotras Cimmperman; Lina Baranauskiene; Simona Jachimoviciūte; Jelena Jachno; Jolanta Torresan; Vilma Michailoviene; Jurgita Matuliene; Jolanta Sereikaite; Vladas Bumelis; Daumantas Matulis
Journal:  Biophys J       Date:  2008-07-03       Impact factor: 4.033

Review 2.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

3.  1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal Structure.

Authors:  Nadine M Shaban; Ke Shi; Ming Li; Hideki Aihara; Reuben S Harris
Journal:  J Mol Biol       Date:  2016-04-30       Impact factor: 5.469

4.  Preparing Poly (Lactic-co-Glycolic Acid) (PLGA) Microspheres Containing Lysozyme-Zinc Precipitate Using a Modified Double Emulsion Method.

Authors:  Nastaran Nafissi Varcheh; Vera Luginbuehl; Reza Aboofazeli; Hans Peter Merkle
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

5.  Continuous capture of recombinant antibodies by ZnCl 2 precipitation without polyethylene glycol.

Authors:  Gregory Dutra; Daniel Komuczki; Alois Jungbauer; Peter Satzer
Journal:  Eng Life Sci       Date:  2020-03-24       Impact factor: 2.678

6.  Continuous integrated antibody precipitation with two-stage tangential flow microfiltration enables constant mass flow.

Authors:  Daniel Burgstaller; Alois Jungbauer; Peter Satzer
Journal:  Biotechnol Bioeng       Date:  2019-01-23       Impact factor: 4.530

Review 7.  Small Endogenous Ligands Modulation of Nerve Growth Factor Bioactivity: A Structural Biology Overview.

Authors:  Francesca Paoletti; Doriano Lamba
Journal:  Cells       Date:  2021-12-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.